Skip to main content

Home

Featured

Interviews
Dr Bryce spoke with IO Learning about current breast cancer treatments and future options for the 1 in 8 women who will ultimately face breast cancer in their lifetime.
Interviews
Dr Philip Low of On Target Laboratories discusses OTL38, a novel, tumor-targeted dye used to guide cancer surgery.
Clinical Insights
We report one of the first cases of successful treatment of vertebral fractures due to metastasis by using the SpineJack System.
Presentation
Dr Riad Salem discusses the pros and cons of streamlining Y90 in UNOS T1/T2 by eliminating the lung shunting study.
Presentation
Dr Eric Soule presents a "CIO Best Abstract" on OX40, a receptor that causes T-cells to divide, increasing their ability to attack cancer.
Back to Top